Bronchiolitis phenotypes identified by latent class analysis may influence the occurrence of respiratory sequelae
No hay miniatura disponible
Archivos
Fecha
2021
Título de la revista
Publicado en
Pediatric Pulmonology, 8755-6863, 2021
Publicado por
John Wiley and Sons Inc
URL de la fuente
ISSN de la revista
Título del volumen
Resumen
Descripción
Abstract
Background
The heterogeneity of bronchiolitis may imply or reflect a different predisposition to respiratory sequelae.
Objective
Our aim was to investigate whether, among infants hospitalized with bronchiolitis, different clinical profiles extracted by latent class analysis (LCA) are associated with different risks of wheezing.
Methods
Over 15 consecutive epidemic seasons (2004–2019), we prospectively enrolled infants <1 year hospitalized for the first episode of bronchiolitis in a single tertiary hospital. A detailed clinical questionnaire was filled for each infant. LCA was applied to differentiate bronchiolitis phenotypes, and after hospital discharge, a phone interview was performed annually to record the presence of wheezing episodes. Adjusted multivariate regression analyses were run to investigate the risk of wheezing during 7 years follow-up according to clinical phenotypes.
Results
LCA performed on 1312 infants resulted in a three-class model. Profile 1 (65.5%): moderate bronchiolitis; Profile 2 (6.1%): severe bronchiolitis; and Profile 3(28.4%): bronchiolitis infants with high eosinophils blood count. At 1 year of follow up, about 50% of children presented wheezing in each profile. Compared to Profile 1, the adjusted odds ratio (OR) of having wheezing episodes was significantly higher in Profile 2 at 2, 3, and 4 years of follow-up. At 7 years, Profile 3 had an adjusted OR = 2.58, higher than Profile 2 (adjusted OR = 2.29).
Conclusions
LCA clearly identified a “moderate”, “severe,” and “high eosinophils blood count” bronchiolitis. During the first 4 years after bronchiolitis, the “severe” profile showed the higher risk of wheezing, but after 7 years this risk seems higher in the “high eosinophils blood count” group